Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 33% ± 19% |
Insufficient scRNA-seq data for expression of RBM15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 530.96 | 459 / 459 | 100% | 11.29 | 1118 / 1118 |
lung | 100% | 713.13 | 578 / 578 | 100% | 10.33 | 1155 / 1155 |
ovary | 100% | 461.37 | 180 / 180 | 100% | 6.82 | 430 / 430 |
uterus | 100% | 379.49 | 170 / 170 | 100% | 13.23 | 459 / 459 |
esophagus | 100% | 401.43 | 1443 / 1445 | 100% | 18.29 | 183 / 183 |
intestine | 100% | 533.31 | 966 / 966 | 100% | 10.53 | 526 / 527 |
stomach | 100% | 435.60 | 359 / 359 | 100% | 12.68 | 285 / 286 |
bladder | 100% | 372.33 | 21 / 21 | 100% | 9.51 | 502 / 504 |
prostate | 100% | 356.18 | 244 / 245 | 100% | 7.98 | 502 / 502 |
liver | 100% | 406.72 | 226 / 226 | 100% | 5.93 | 404 / 406 |
thymus | 100% | 454.17 | 652 / 653 | 100% | 7.47 | 602 / 605 |
pancreas | 100% | 262.32 | 327 / 328 | 99% | 8.74 | 177 / 178 |
skin | 100% | 573.54 | 1808 / 1809 | 99% | 11.01 | 466 / 472 |
kidney | 100% | 356.69 | 89 / 89 | 98% | 7.13 | 881 / 901 |
brain | 97% | 250.65 | 2563 / 2642 | 100% | 7.85 | 705 / 705 |
adrenal gland | 100% | 461.84 | 258 / 258 | 95% | 4.97 | 219 / 230 |
adipose | 100% | 581.66 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.75 | 29 / 29 |
muscle | 100% | 692.34 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 832.51 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 14.69 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.90 | 1 / 1 |
blood vessel | 100% | 379.91 | 1332 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 976.44 | 915 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 374.25 | 842 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 5.20 | 74 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009048 | Biological process | dosage compensation by inactivation of X chromosome |
GO_0045638 | Biological process | negative regulation of myeloid cell differentiation |
GO_0001510 | Biological process | RNA methylation |
GO_0045652 | Biological process | regulation of megakaryocyte differentiation |
GO_0038163 | Biological process | thrombopoietin-mediated signaling pathway |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0048536 | Biological process | spleen development |
GO_0007221 | Biological process | positive regulation of transcription of Notch receptor target |
GO_0001569 | Biological process | branching involved in blood vessel morphogenesis |
GO_0060674 | Biological process | placenta blood vessel development |
GO_0060412 | Biological process | ventricular septum morphogenesis |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0036396 | Cellular component | RNA N6-methyladenosine methyltransferase complex |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005634 | Cellular component | nucleus |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RBM15 |
Protein name | RNA binding motif protein 15 RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15) |
Synonyms | OTT1 OTT |
Description | FUNCTION: RNA-binding protein that acts as a key regulator of N6-methyladenosine (m6A) methylation of RNAs, thereby regulating different processes, such as hematopoietic cell homeostasis, alternative splicing of mRNAs and X chromosome inactivation mediated by Xist RNA . Associated component of the WMM complex, a complex that mediates N6-methyladenosine (m6A) methylation of RNAs, a modification that plays a role in the efficiency of mRNA splicing and RNA processing (By similarity). Plays a key role in m6A methylation, possibly by binding target RNAs and recruiting the WMM complex . Involved in random X inactivation mediated by Xist RNA: acts by binding Xist RNA and recruiting the WMM complex, which mediates m6A methylation, leading to target YTHDC1 reader on Xist RNA and promoting transcription repression activity of Xist . Required for the development of multiple tissues, such as the maintenance of the homeostasis of long-term hematopoietic stem cells and for megakaryocyte (MK) and B-cell differentiation (By similarity). Regulates megakaryocyte differentiation by regulating alternative splicing of genes important for megakaryocyte differentiation; probably regulates alternative splicing via m6A regulation . Required for placental vascular branching morphogenesis and embryonic development of the heart and spleen (By similarity). Acts as a regulator of thrombopoietin response in hematopoietic stem cells by regulating alternative splicing of MPL (By similarity). May also function as an mRNA export factor, stimulating export and expression of RTE-containing mRNAs which are present in many retrotransposons that require to be exported prior to splicing . High affinity binding of pre-mRNA to RBM15 may allow targeting of the mRNP to the export helicase DBP5 in a manner that is independent of splicing-mediated NXF1 deposition, resulting in export prior to splicing . May be implicated in HOX gene regulation . . |
Accessions | A0A499FJY3 ENST00000654015.1 ENST00000369784.9 [Q96T37-1] ENST00000652342.2 [Q96T37-4] A0A087WWP4 ENST00000487146.8 [Q96T37-3] ENST00000652747.1 [Q96T37-3] ENST00000650953.2 Q96T37 ENST00000602849.1 [Q96T37-2] ENST00000618772.4 [Q96T37-1] A0A494C001 ENST00000617047.1 |